SEC Form 4 · accession 0001162194-16-000250
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Christopher Linthwaite
Officer — President & CEO
Period of report
Nov 8, 2016
Accepted (ET)
Nov 10, 2016 · 3:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $4.99 | Nov 8, 2016 | A | 140,000 | A | — | Nov 8, 2026 | Common Stock | 140,000 | 140,000 | D |
Explanation of responses
- F112/48th of the total number of shares subject to the Option will vest and become exercisable on October 19, 2017 and 1/48th of the total number of shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that all shares subject to the Option will be fully vested and exercisable on October 19, 2020, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date.